Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation  Kirsten M. Williams, MD, Guang-Shing Cheng, MD, Iskra Pusic, MD, Madan H. Jagasia, MD, MBBS, MS, Linda J. Burns, MD, Vincent T. Ho, MD, Joseph Pidala, MD, PhD, Jeanne Palmer, MD, Laura Johnston, MD, Sebastian Mayer, MD, David A. Jacobsohn, MD, Paul J. Martin, MD, Barry E. Storer, PhD, Yoshihiro Inamoto, MD PhD, Xiaoyu Chai, MS, Mary E.D. Flowers, MD, Stephanie J. Lee, MD, MPH  Biology of Blood and Marrow Transplantation  Volume 21, Issue 2, Pages S61-S62 (February 2015) DOI: 10.1016/j.bbmt.2014.11.062 Copyright © 2015 Terms and Conditions

Figure Change in individual and mean percentage FEV1% over time. Biology of Blood and Marrow Transplantation 2015 21, S61-S62DOI: (10.1016/j.bbmt.2014.11.062) Copyright © 2015 Terms and Conditions